Idiopathic pulmonary fibrosis pathophysiology: Difference between revisions

Jump to navigation Jump to search
(Replaced content with "__NOTOC__ {{Idiopathic pulmonary fibrosis }} {{CMG}}; {{AE}} {{AEL}} ==Overview== ==Pathophysiology== ==Genetics== ==Microscopic pathology== ==Gross pathology== ==Re...")
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Idiopathic pulmonary fibrosis }}
{{Idiopathic pulmonary fibrosis }}
{{CMG}}
{{CMG}}; {{AE}} {{AEL}}  
==Overview==
==Overview==
==Pathophysiology==
==Pathophysiology==  
Pulmonary fibrosis has often been called an [[autoimmunity|autoimmune disease]].  However, it is perhaps better characterized as an abnormal and excessive deposition of fibrotic tissue in the pulmonary interstitium with minimal associated inflammation.<ref name="Selman">{{cite journal |last=Selman |first=Moisés |coauthors=Talmadge E. King, Jr.; and Annie Pardo |title=Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy |journal=Annals of Internal Medicine |year=2001 |volume=134 |number=2 |pages=136-51 |url=http://www.annals.org/cgi/content/abstract/134/2/136}}</ref>  [[Autoantibodies]], a hallmark of autoimmune diseases, are found in a minority of patients with truly idiopathic pulmonary fibrosis.  Moreover, many autoimmune diseases associated with "pulmonary fibrosis", such as scleroderma, are more frequently associated with a related but more inflammatory disease, nonspecific interstitial pneumonitis.<ref>{{cite journal |last=King, Jr. |first=Talmadge E. |title=Centennial review: clinical advances in the diagnosis and therapy of the interstitial lung diseases |url=http://ajrccm.atsjournals.org/cgi/content/full/172/3/268 |journal=American Journal of Respiratory and Critical Care Medicine |year=2005 |volume=172 |number=3 |pages=268-79}}</ref> It is associated with [[smoking]]<ref>{{cite journal |last=Nagai |first=Sonoko |coauthors=Yuma Hoshino, Michio Hayashi, Isao Ito |title=Smoking-related interstitial lung diseases |url=http://www.co-pulmonarymedicine.com/pt/re/copulmonary/abstract.00063198-200009000-00005.htm |journal=Current Opinion in Pulmonary Medicine |volume=6 |issue=5 |pages=415-9 |year=2000 |pmid=10958232}}</ref> and exhibits some dependency on the amount of smoking.<ref>{{cite journal |last=Baumgartner |first=KB |coauthors=Samet JM, Stidley CA, Colby TV, Waldron JA |title=Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis |url= http://ajrccm.atsjournals.org/cgi/content/short/155/1/242 |journal=American Journal of Respiratory and Critical Care Medicine |volume=155 |number=1 |pages=242-248 |year=1997 |pmid=9001319}}</ref>
==Genetics==  
 
==Microscopic pathology==  
==Pathology==
==Gross pathology==  
;Histology
{{main article|Usual interstitial pneumonia}}
 
[[Image:Usual interstitial pneumonia (1).JPG|left|200px|thumb|[[Micrograph]] of usual interstitial pneumonia (UIP). UIP most often represents '''idiopathic pulmonary fibrosis'''. [[H&E stain]]. [[Autopsy]] specimen.]]
 
[[Histology|Histologic]] specimens for the diagnosis of IPF must be large enough that the pathologist can comment on the underlying lung architecture. 
 
Small biopsies, such as those obtained via transbronchial lung biopsy (performed during [[bronchoscopy]]) are generally not sufficient for this purpose.  Hence, larger biopsies obtained surgically via a thoracotomy or thoracoscopy are usually necessary.
 
The histological pattern of fibrosis associated with '''IPF''' is referred to as usual interstitial pneumonia (UIP).
 
Although '''UIP''' is required for the diagnosis of '''IPF''', it can be seen in other diseases as well.<ref>{{cite book |title=Robbins and Cotran's Pathological Basis of Disease |edition=7th ed. |first=Vinay |last=Kumar |coauthors=Nelso Fausto and Abul Abbas |year=2005 |publisher=Saunders |isbn=978-0721601878 |pages=729}}</ref> 
 
Key features of UIP include fibroblast foci, a pattern of temporal heterogeneity, dense interstitial fibrosis in a paraseptal and subpleural distribution, and a relatively mild or minor component of interstitial chronic inflammation.<ref name=ATS2/>  To help narrow the differential diagnosis, an absence of significant [[granuloma|granulomatous]] inflammation, [[microorganism]]s, [[eosinophil]]s, and [[asbestosis|asbestos bodies]] is required.


==References==
==References==

Revision as of 14:55, 14 February 2018

Idiopathic pulmonary fibrosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Idiopathic pulmonary fibrosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Idiopathic pulmonary fibrosis pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Idiopathic pulmonary fibrosis pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Idiopathic pulmonary fibrosis pathophysiology

CDC on Idiopathic pulmonary fibrosis pathophysiology

Idiopathic pulmonary fibrosis pathophysiology in the news

Blogs on Idiopathic pulmonary fibrosis pathophysiology

Directions to Hospitals Treating Idiopathic pulmonary fibrosis

Risk calculators and risk factors for Idiopathic pulmonary fibrosis pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]

Overview

Pathophysiology

Genetics

Microscopic pathology

Gross pathology

References

Template:WH Template:WS